To shield against US President Donald Trump's tariff shock, analysts have been advising investors to focus on stocks of domestic-oriented companies, rather than export-centric ones, to minimise potential losses.
Investors with high risk appetite must stay invested while risk-averse investors can consider profit booking.
Deal to bolster firm's position in healthcare IT.
